latest update:
[RxAtlas]

drug summary · 2 NDC codes

PYRUKYND 5 mg/1

mitapivat

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 48248NDC codes 2application NDA216196RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namemitapivat
active ingredientsMITAPIVAT
dosage formTABLET, FILM COATED
routeORAL
strength5 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA216196
ATC codenot reported
RxCUInot reported
manufacturerAgios Pharmaceuticals, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classCytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; P-Glycoprotein Inhibitors [MoA]; Pyruvate Kinase Activator [EPC]; Pyruvate Kinase Activators [MoA]; UGT1A1 Inducers [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
71334-205—
71334020505—

Other mitapivat products

3 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.